Who owns Eagle Pharmaceuticals?
- Ticker: EGRX
- CUSIP Number: 269796108
Tip: Access positions for across all investors
Analyze quarterly positions in Eagle Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eagle Pharmaceuticals stock
Who bought or sold Eagle Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.3M | $6.6M | 100% | Mar 2024 |
|
| AIGH Capital Management | 1.2M | $6.2M | 100% | Mar 2024 |
|
| BlackRock | 898k | $4.7M | 1% | Mar 2024 |
|
| AQR Capital Management | 879k | $4.6M | 78% | Mar 2024 |
|
| Vanguard Group | 641k | $3.4M | 0% | Mar 2024 |
|
| Morgan Stanley | 375k | $2.0M | 129% | Mar 2024 |
|
| LSV Asset Management | 334k | $1.8M | -15% | Mar 2024 |
|
| Bank of America Corporation | 326k | $1.7M | 74% | Mar 2024 |
|
| J. Goldman & Co | 259k | $1.4M | -23% | Mar 2024 |
|
| Millennium Management | 258k | $1.4M | -51% | Mar 2024 |
|
| Marshall Wace | 258k | $1.3M | 79% | Mar 2024 |
|
| Two Sigma Advisers | 236k | $1.2M | 6% | Mar 2024 |
|
| Geode Capital Management | 232k | $1.2M | 5% | Mar 2024 |
|
| D. E. Shaw & Co | 220k | $1.2M | 34% | Mar 2024 |
|
| Thomas Stevens, CFA" | 192k | $1.0M | 110% | Mar 2024 |
|
| Assenagon Asset Management | 185k | $971k | -15% | Mar 2024 |
|
| Goldman Sachs Group | 178k | $932k | -8% | Mar 2024 |
|
| Dimensional Fund Advisors | 171k | $897k | -31% | Mar 2024 |
|
| Two Sigma Investments | 163k | $856k | -21% | Mar 2024 |
|
| Trexquant Investment | 126k | $661k | 88% | Dec 2023 |
|
| American Century Companies | 123k | $645k | 25% | Mar 2024 |
|
| Tang Capital Management | 119k | $623k | 0% | Mar 2024 |
|
| Man Group | 105k | $551k | 71% | Mar 2024 |
|
| Northern Trust | 100k | $521k | 2% | Mar 2024 |
|
| Charles Schwab Investment Management | 74k | $387k | 2% | Mar 2024 |
|
| DGS Capital Management | 62k | $325k | 442% | Mar 2024 |
|
| Jpmorgan Chase & Co | 59k | $307k | -5% | Mar 2024 |
|
| Kennedy Capital Management | 56k | $292k | -24% | Mar 2024 |
|
| Citadel Advisors | 53k | $276k | -36% | Mar 2024 |
|
| Acadian Asset Management | 52k | $274k | -78% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 49k | $256k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 42k | $221k | -70% | Mar 2024 |
|
| Susquehanna International | 41k | $217k | -3% | Mar 2024 |
|
| Jump Financial | 39k | $203k | 172% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 37k | $196k | -58% | Mar 2024 |
|
| Bank of New York Mellon | 35k | $185k | -16% | Mar 2024 |
|
| Bridgeway Capital Management | 32k | $167k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 28k | $147k | 692% | Mar 2024 |
|
| PDT Partners | 27k | $142k | 100% | Mar 2024 |
|
| Denali Advisors | 27k | $139k | 0% | Mar 2024 |
|
| Bank Of Montreal | 26k | $137k | 100% | Mar 2024 |
|
| Barclays | 23k | $119k | -24% | Mar 2024 |
|
| FMR | 22k | $116k | 16% | Mar 2024 |
|
| State of Wyoming | 22k | $113k | 100% | Mar 2024 |
|
| Alliancebernstein | 21k | $112k | 0% | Dec 2023 |
|
| Occudo Quantitative Strategies | 19k | $102k | -58% | Mar 2024 |
|
| Rhumbline Advisers | 17k | $90k | -1% | Mar 2024 |
|
| Savant Capital Management | 17k | $87k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 16k | $83k | 100% | Mar 2024 |
|
| William Blair $ Company | 14k | $74k | -19% | Mar 2024 |
|
| Royce & Associates | 14k | $72k | 100% | Mar 2024 |
|
| UBS Group | 12k | $64k | 46% | Mar 2024 |
|
| Stanley-Laman | 12k | $63k | 0% | Mar 2024 |
|
| Hsbc Holdings | 12k | $63k | 100% | Dec 2023 |
|
| Wintrust Financial Corporation | 11k | $60k | 100% | Mar 2024 |
|
| AJOVista | 11k | $59k | 100% | Mar 2024 |
|
| Jacobs Levy Equity Management | 10k | $54k | -34% | Mar 2024 |
|
| Sei Investments | 10k | $54k | -84% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 8.7k | $45k | -5% | Mar 2024 |
|
| Headlands Technologies | 6.6k | $35k | 76% | Mar 2024 |
|
| New York State Common Retirement Fund | 6.4k | $33k | 0% | Mar 2024 |
|
| WealthCollab | 5.3k | $28k | 109% | Mar 2024 |
|
| American International | 5.1k | $27k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 4.0k | $21k | 24% | Mar 2024 |
|
| Qube Research & Technologies | 3.6k | $19k | -80% | Mar 2024 |
|
| Tower Research Capital | 3.5k | $19k | 275% | Mar 2024 |
|
| Citigroup | 2.7k | $14k | 56% | Mar 2024 |
|
| Russell Investments | 2.3k | $12k | -84% | Mar 2024 |
|
| CWM | 2.2k | $12k | -48% | Mar 2024 |
|
| GAMMA Investing | 1.7k | $8.8k | 100% | Mar 2024 |
|
| Quantbot Technologies | 1.2k | $6.3k | -50% | Mar 2024 |
|
| Federated Investors | 1.2k | $6.2k | 100% | Dec 2023 |
|
| California State Teachers Retirement System | 1.0k | $5.5k | -54% | Mar 2024 |
|
| Summit Investment Advisors | 867.00 | $4.5k | 0% | Mar 2024 |
|
| Legal & General Group | 819.00 | $4.3k | 0% | Mar 2024 |
|
| Amalgamated Bank | 394.00 | $2.0k | -58% | Mar 2024 |
|
| Archer Investment Corp | 350.00 | $1.8k | 0% | Mar 2024 |
|
| Group One Trading | 285.00 | $1.5k | 100% | Mar 2024 |
|
| Capital Advisors | 175.00 | $1.0k | 100% | Mar 2024 |
|
| Massmutual Trust | 170.00 | $891.004000 | 100% | Mar 2024 |
|
| Advisor Group Holdings | 166.00 | $868.993400 | -90% | Mar 2024 |
|
| Fortitude Family Office | 117.00 | $612.998100 | 100% | Mar 2024 |
|
| Barrett & Company | 100.00 | $524.000000 | 0% | Mar 2024 |
|
| Nordwand Advisors | 100.00 | $524.000000 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 88.00 | $419.997600 | -4% | Mar 2024 |
|
| Front Row Advisors | 40.00 | $210.000000 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $10.000000 | 100% | Mar 2024 |
|